Myricetin Restores Autophagy to Attenuate Lumbar Intervertebral Disk Degeneration Via Negative Regulation of the JAK2/STAT3 Pathway

Autophagy is a critical player in lumbar intervertebral disk degeneration (IDD), and Autophagy activation has been suggested to prevent the Apoptosis of nucleus pulposus cells (NPCs). Myricetin has anti-cancer, anti-inflammatory, and antioxidant potentials and can activate Autophagy. Thus, this study focused on the roles and mechanisms of myricetin in IDD. A puncture-induced rat IDD model was established and intraperitoneally injected with 20-mg/kg/day myricetin. Histopathological changes of intervertebral disks (IVDs) were assessed by hematoxylin and eosin staining and Safranin O/Fast Green staining. The isolated NPCs from IVDs of healthy rats were stimulated with IL-1β to mimic IDD-like conditions. The roles of myricetin in cell Apoptosis, extracellular matrix (ECM) degradation, Autophagy repression, and the JAK2/STAT3 pathway activation were examined by cell counting kit-8, flow cytometry, western blotting, real-time quantitative polymerase chain reaction, and immunofluorescence staining. Myricetin treatment attenuated the Apoptosis and ECM degradation, and enhanced Autophagy in the IL-1β-treated NPCs, whereas the myricetin-mediated protection was limited by Autophagy inhibition. Mechanistically, myricetin activated Autophagy through blocking the JAK2/STAT3 signaling. In vivo experiments revealed that intraperitoneal injection of myricetin activated NPC Autophagy to relieve puncture injury in rats. Myricetin prevents IDD by attenuating NPC Apoptosis and ECM degradation through blocking the JAK2/STAT3 pathway to enhance Autophagy.

Autophagy; ECM; Intervertebral disk degeneration; Myricetin; NPC.